3 Healthcare Stocks That Are Better Than Tesla Right Now
It's a big reason Tesla is approaching an $800 billion valuation and its stock is up 1,500% in the past two years. Jason Hawthorne (Moderna): When Moderna went public in late 2018, it was the biggest biotech initial public offering in history. The company aimed to use mRNA as "the software of life" to program cells, instructing them to make whatever proteins served the needed function in the body.